Dabur recently announced its plans to acquire Badshah Masala.
The Burman family started creating a go-to name for everything Ayurveda a hundred and twenty years back.
Ayurveda, as a market, still at large, is unorganized and unregulated because:
• Lack of emphasis/funds devoted to R&D
• Unavailability of modern documentation around Ayurvedic Treatments
• The Pharma Bros muscling around and focusing more on symptomatic treatment instead of the root cause
Despite Ayurveda being thousands of years old, somewhere, it has not received the popularity tag it deserves – as a school of medicine and a way of living.
Most Ayurvedic practitioners and institutions still draw inspiration from old Sanskrit books like Charak Samhita, Shushrut Samhita, Bhava Prakash Nighantu and others. Dr S.K. Burman was ahead of his time to realize that to promote Ayurveda, and we would need the amalgamation of modern scientific methodology and age-old Ayurvedic principles.
In 1919, Dabur started setting up laboratories to develop scientific processes and quality check mechanisms as they began producing bulk producing Ayurvedic medicines for the masses. In 1957, the brand started computerizing its operations – once again, still early on its journey to identify the growing power of technology and the leverage it can offer.
Coincidentally and unknowingly, as I write about Dabur’s journey – I cannot help but find similarities in what we’ve been trying to build at Amrutam. In the past five years, we have tried to set up an in-house laboratory to ensure the standardized quality of all Ayurvedic recipes – we’ve to offer and then, as a second step, we also implemented Enterprise Resource Planning Modules to integrate all the systems, which were in place digitally and on the cloud – these have been massive projects we have tinkled around with as a team and as a keep reminding myself and all of the team – it’s still day zero for us.
Our vision is to build accessible resources for the Ayurvedic community and help the country start adapting preventive lifestyle practices.
Prevention is always better than cure.
Dabur closed FY 2022 with a whopping scale of ten thousand crores, and the brand’s recent announcement of acquisition is only a positive sign that we are just getting started; it’s also a strategic move to grow horizontally as now the brand has reached an unprecedented scale and penetration in the Ayurveda landscape.
What are your thoughts?